Orencia _ 250 Mg 250 mg Lyophilisate for solution for infusion.
PDF Leaflet Revision Date: 20 January 2026
Clinical Summary
Quick overview from the medicine insert
Indication
For adult rheumatoid arthritis and juvenile idiopathic arthritis.
Dosage (summary)
Adults: 30 min IV infusion based on weight; Pediatric: 10 mg/kg for <75 kg, adult dosing for u226575 kg.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- TNF blocking agents
- Anakinra
Contraindications
- Hypersensitivity to abatacept
- Active tuberculosis
Common side effects
- Headache
- Nausea
- Upper respiratory tract infection
Counselling Points
- Monitor for infections
- Avoid live vaccines
- Do not use siliconized syringes
Serious warnings
- Risk of serious infections
- Anaphylaxis possible
Important Disclaimer
The Orencia _ 250 Mg 250 mg Lyophilisate for solution for infusion. professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
